November 10, 2025

Alkermes plc (ALKS) Stock Analysis: A 33% Upside Potential and Robust Revenue Growth in the Biopharma Sector

Alkermes plc (NASDAQ: ALKS), an Ireland-based biopharmaceutical company, is attracting considerable attention from investors due to its strong positioning in the healthcare sector, particularly within the drug manufacturers—specialty and generic..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unveiling a 34% Upside Potential in the Biotech Sector

BridgeBio Pharma, Inc. (BBIO), a prominent player in the biotechnology sector, is drawing investor attention with its substantial market cap of $11.91 billion and a compelling potential upside of 34.48%,..

Glaukos Corporation (GKOS) Investor Outlook: Unlocking a 43.69% Potential Upside in Medical Devices

Glaukos Corporation (NYSE: GKOS) stands out in the healthcare sector as a dynamic player in the medical devices industry, focusing on innovative treatments for ophthalmic conditions. With a market capitalization..

Elanco Animal Health (ELAN) Stock Analysis: Exploring a 8.30% Upside Potential

Elanco Animal Health Incorporated (NYSE: ELAN), a leader in the healthcare sector’s drug manufacturing for both specialty and generic products, is showcasing promising growth potential for investors keen on the..

Option Care Health, Inc. (OPCH) Stock Analysis: Healthcare Growth and a 27% Upside Potential

Option Care Health, Inc. (OPCH), a prominent player in the healthcare sector, offers investors a unique opportunity within the medical care facilities industry. With a market capitalization of $4.39 billion,..

Integer Holdings Corporation (ITGR): Investor Outlook with 24% Potential Upside

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors seeking exposure to the growth of..

Jazz Pharmaceuticals plc (JAZZ) Investor Outlook: Exploring a 44% Potential Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, offers an intriguing investment opportunity with its substantial potential upside of 44.01%. Headquartered in Dublin, Ireland, Jazz Pharmaceuticals..

Legend Biotech Corporation (LEGN) Stock Analysis: Unveiling a 136% Potential Upside in the Biotech Sector

Legend Biotech Corporation (NASDAQ: LEGN) has been capturing attention in the biotechnology sector with its innovative approach to cell therapy, particularly in oncology. Despite the stock’s modest performance recently, its..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: High Growth in Healthcare with 9.49% Upside

Madrigal Pharmaceuticals, Inc. (MDGL) has been capturing the attention of investors looking for promising opportunities in the healthcare sector, specifically within biotechnology. With a market capitalization of $11.11 billion, Madrigal..

Avantor, Inc. (AVTR) Stock Analysis: Exploring an 18% Potential Upside for Investors

Avantor, Inc. (NYSE: AVTR), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $7.87 billion, Avantor provides mission-critical products..

Teleflex Incorporated (TFX): Investor Outlook Reveals 13.48% Potential Upside Amidst Robust Revenue Growth

Teleflex Incorporated (NYSE: TFX) is a prominent player within the healthcare sector, specifically in the medical instruments and supplies industry. With a market capitalization of $4.83 billion, this American company..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Healthcare Innovator with 19% Potential Upside

TransMedics Group, Inc. (NASDAQ: TMDX) has carved a niche for itself in the healthcare sector, specifically within the medical devices industry. Known for its innovative approach to organ transplant therapy,..

Hologic, Inc. (HOLX) Stock Analysis: Navigating a Promising Terrain in Women’s Health with a 2% Potential Upside

Hologic, Inc. (HOLX), a stalwart in the healthcare sector, has carved a formidable niche in the medical instruments and supplies industry. With a market capitalization of $16.49 billion, the company..

Moderna, Inc. (MRNA) Investor Outlook: Exploring a Potential 63.61% Upside Amidst Revenue Challenges

Moderna, Inc. (NASDAQ: MRNA), a leader in the biotechnology sector, has been a focal point for investors seeking to understand the evolving landscape of mRNA technology and its broad applications...

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 30% Potential Upside

Prestige Consumer Healthcare Inc. (NYSE: PBH) presents an intriguing opportunity for investors in the healthcare sector, particularly within the niche of over-the-counter (OTC) health and personal care products. With a..

Ionis Pharmaceuticals, Inc. (IONS): Investor Outlook Highlights 13% Potential Upside Amid Robust Pipeline and Strategic Collaborations

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) has emerged as a formidable player in the biotechnology sector, captivating investor interest with its innovative RNA-targeted medicines. With a market capitalization of $11.91 billion,..

Natera, Inc. (NTRA) Stock Analysis: A Healthcare Leader with Strong Growth Potential and a 9.55% Upside

Natera, Inc. (NASDAQ: NTRA) stands out in the healthcare sector as a formidable player in the diagnostics and research industry. With a current market capitalization of $27.54 billion and a..

Bio-Techne Corp (TECH) Stock Analysis: Unpacking a Promising 18.88% Potential Upside

Bio-Techne Corp (NASDAQ: TECH), a notable player in the biotechnology sector, is capturing the attention of investors with its strong growth potential and a promising 18.88% potential upside. Headquartered in..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A Deep Dive into Its 25.96% Potential Upside

iRhythm Technologies, Inc. (NASDAQ: IRTC) stands out in the healthcare sector, particularly in the medical devices industry, as it continues to capture investor attention with its innovative approach to cardiac..

Waters Corporation (WAT) Stock Analysis: A Stable Player with a 4.35% Upside Potential in the Healthcare Sector

Waters Corporation (NYSE: WAT), with a commanding presence in the Healthcare sector’s Diagnostics & Research industry, has been a reliable performer for investors seeking stability and growth. With a market..

Search

Funds

November 10, 2025

Search

Funds

November 10, 2025

FTSE 100

Funds